EP0800829A4

Antitumor agent potentiator comprising il-6 antagonist

Abstract

This record has no abstract on file.

Term

Term ended

Projected expiry passed 28 December 2015, 10.7 years ago.

Every citation, both waysCites: the store holds 4 of 5

Citations
Document	Relation	Office	Category	Cited during	Relevant claims
EP0312996A2	Cites	European Patent Office (EPO)	XY	Search report	1-4,7,12-14
EP0430193A1	Cites	European Patent Office (EPO)	X	Search report	1-4,7,12-14
EP0312996A	Cites	European Patent Office (EPO)	–	–	–
EP0430193A	Cites	European Patent Office (EPO)	–	–	–
SATO K ET AL: "Reshaping a human antibody to inhibit the interleukin 6 -dependent tumor cell growth.", CANCER RESEARCH, vol. 53, no. 4, 15 February 1993 (1993-02-15), pages 851 - 6, XP002119558	Non-patent	–	–	Search report	–
TANAKA Y ET AL: "Interleukin - 6 as cachexia mediator in experimental cancer models (Meeting abstract).", PROC ANNU MEET AM ASSOC CANCER RES, vol. 34, March 1993 (1993-03-01), pages A1165, XP002119559	Non-patent	–	–	Search report	–
MIZUTANI Y ET AL: "Enhanced sensitivity of human renal cell carcinoma cells to cisplatin by anti- IL - 6 monoclonal antibody or anti- IL - 6 receptor monoclonal antibody (Meeting abstract).", PROC ANNU MEET AM ASSOC CANCER RES, vol. 36, March 1995 (1995-03-01), pages A2027, XP002119560	Non-patent	–	–	Search report	–
MIZUTANI Y ET AL: "Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti- interleukin 6 monoclonal antibody or anti- interleukin 6 receptor monoclonal antibody.", CANCER RESEARCH, vol. 55, no. 3, 1 February 1995 (1995-02-01), pages 590 - 6, XP002119561	Non-patent	–	–	Search report	–
BORSELLINO N ET AL: "Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines.", CANCER RESEARCH, vol. 55, no. 20, 15 October 1995 (1995-10-15), pages 4633 - 9, XP002119562	Non-patent	–	–	Search report	–
See also references of WO 9620728A1	Non-patent	–	–	Search report	–

25 members in 12 offices; this record represents the family

This recordMember, by publication datePriority claim2 more offices are in the list below

Priority claims7

Priority claims
Document	Office	Kind	Date
34042594	Japan	–	1994-12-29
34042594	Japan	A	1994-12-29
34042594	Japan	A	1994-12-29
9502769	Japan	W	1995-12-28
9502769	Japan	W	1995-12-28
JP19940340425	–	–	–
WO1995JP02769	–	–	–

Members25

Family members, oldest first
Document	Office	Kind
CA2209124A1	Canada	A1	1996-07-11
WO9620728A1	World Intellectual Property Organization (WIPO)	A1	1996-07-11
AU4356896A	Australia	A	1996-07-24
JPH08231433A	Japan	A	1996-09-10
EP0800829A1	European Patent Office (EPO)	A1	1997-10-15
CN1174507A	China	A	1998-02-25
HK1001512A1	Hong Kong, China	A1	1998-06-26
AU704723B2	Australia	B2	1999-04-29
EP0800829A4This record	European Patent Office (EPO)	A4	1999-12-22
US6086874A	United States of America	A	2000-07-11
KR100252743B1	Republic of Korea	B1	2000-09-01
CN1075387C	China	C	2001-11-28
EP0800829B1	European Patent Office (EPO)	B1	2002-03-20
AT214602T	Austria	T	2002-04-15
ATE214602T1	Austria	T1	2002-04-15
DE69525971D1	Germany	D1	2002-04-25
ES2170815T3	Spain	T3	2002-08-16
DE69525971T2	Germany	T2	2002-11-28
JP2008063344A	Japan	A	2008-03-21
JP4079461B2	Japan	B2	2008-04-23
CA2209124C	Canada	C	2010-03-23
JP4812736B2	Japan	B2	2011-11-09
EP0800829B2	European Patent Office (EPO)	B2	2012-07-25
ES2170815T5	Spain	T5	2012-11-14
DE69525971T3	Germany	T3	2013-01-10

73 legal events, as 7 offices reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code	Office
2016-06-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-04-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2015-03-27	Announcement of lapse in spainLapsedFD2A	FD2A	ES
2014-11-28	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2014-11-28	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2014-10-31	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2014-09-26	Notification of lapseLapsedST	ST	FR
2014-09-25	Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119	R119	DE
2014-08-27	Gb: european patent ceased through non-payment of renewal feeCeasedGBPC	GBPC	EP
2014-07-01	Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119	R119	DE
2013-04-30	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2013-03-29	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2013-02-28	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2013-02-28	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2013-02-28	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2012-11-14	Patent modifiedDC2A	DC2A	ES
2012-09-13	Epo decision maintaining patent in amended form now finalR102	R102	DE
2012-07-25	Patent maintained in amended form27A	27A	EP
2012-07-25	Designated contracting statesAK	AK	EP
2012-06-22	Patent maintained in amended formORIGINAL CODE: 0009272PUAH	PUAH	EP
2012-06-22	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: PATENT MAINTAINED AS AMENDEDSTAA	STAA	EP
2012-04-04	Title (correction)USE OF A PM-1 ANTIBODY OR OF A MH 166 ANTIBODY FOR ENHANCING THE ANTI-TUMOR EFFECT OF CISPLATIN OR CARBOPLATINRTI2	RTI2	EP
2011-08-30	Reply to examination report in opposition receivedOppositionORIGINAL CODE: EPIDOSNORE3PLBC	PLBC	EP
2011-06-20	Information related to despatch of examination report in opposition + time limit modifiedOppositionORIGINAL CODE: EPIDOSCORE2PLAH	PLAH	EP
2011-04-08	Information related to despatch of examination report in opposition + time limit modifiedOppositionORIGINAL CODE: EPIDOSCORE2PLAH	PLAH	EP
2010-12-03	Examination report in opposition despatched + time limitOppositionORIGINAL CODE: EPIDOSNORE2PLAY	PLAY	EP
2010-02-24	Opposition filed (corrected)OppositionR26	R26	EP
2010-02-09	Appeal procedure closedAppealORIGINAL CODE: EPIDOSNNOA9OAPBU	APBU	EP
2010-01-22	Opposition data, opponent's data or that of the opponent's representative modifiedOppositionORIGINAL CODE: 0009299OPPOPLAB	PLAB	EP
2007-05-16	Date of receipt of statement of grounds of appeal recordedAppealORIGINAL CODE: EPIDOSNNOA3OAPBQ	APBQ	EP
2007-03-03	Appeal reference modifiedAppealORIGINAL CODE: EPIDOSCREFNOAPAH	APAH	EP
2007-03-01	Date of receipt of notice of appeal recordedAppealORIGINAL CODE: EPIDOSNNOA2OAPBP	APBP	EP
2006-12-21	Communication despatched that patent is revokedRevokedORIGINAL CODE: EPIDOSNREV1RDAF	RDAF	EP
2003-10-01	Patent lapsedLapsedMM4A	MM4A	IE
2003-08-29	Reply of patent proprietor to notice(s) of opposition receivedOppositionORIGINAL CODE: EPIDOSNOBS3PLBB	PLBB	EP
2003-08-07	Notice of opposition and request to file observation + time limit sentOppositionORIGINAL CODE: EPIDOSNOBS2PLAX	PLAX	EP
2003-07-01	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2003-02-26	Opposition filedOpposition26	26	EP
2003-02-10	Reply of patent proprietor to notice(s) of oppositionOppositionORIGINAL CODE: EPIDOS OBSOPLBF	PLBF	EP
2003-01-11	Opposition filedOppositionORIGINAL CODE: 0009260PLBI	PLBI	EP
2002-12-30	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2002-12-28	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2002-12-23	Unpublished change to opponent dataORIGINAL CODE: EPIDOS OPPOPLBQ	PLBQ	EP
2002-09-30	Patent ceasedCeasedPL	PL	CH
2002-09-02	Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents actLapsedNLV1	NLV1	EP
2002-08-23	Fr: translation filedET	ET	EP
2002-08-16	Definitive protectionFG2A	FG2A	ES
2002-06-20	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2002-06-20	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2002-06-20	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2002-04-25	Corresponds to:REF	REF	EP
2002-03-28	European patent takes effect as a national patent in ch/liEP	EP	CH
2002-03-20	Designated contracting statesAK	AK	EP
2002-03-20	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2002-03-20	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2002-03-20	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2002-03-20	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2002-03-20	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2002-03-20	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2002-03-20	Corresponds to:REF	REF	EP
2002-02-01	(expected) grantORIGINAL CODE: 0009210GRAA	GRAA	EP
2002-01-01	European patent in force as of 2002-01-01IF02	IF02	GB
2001-10-25	Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOS IGRAGRAH	GRAH	EP
2001-07-11	Despatch of communication of intention to grantORIGINAL CODE: EPIDOS AGRAGRAG	GRAG	EP
2001-07-11	Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOS IGRAGRAH	GRAH	EP
2001-03-16	Despatch of communication of intention to grantORIGINAL CODE: EPIDOS AGRAGRAG	GRAG	EP
2000-08-30	First examination report despatched17Q	17Q	EP
1999-12-22	Supplementary search report drawn up and despatchedA4	A4	EP
1999-12-22	Designated contracting statesAK	AK	EP
1999-12-15	Information provided on ipc code assigned before grant6A 61K 31/28 A, 6A 61K 33/24 B, 6A 61K 38/00 B, 6A 61K 45/00 B, 6A 61K 39/395 BRIC1	RIC1	EP
1997-10-15	Request for examination filed17P	17P	EP
1997-10-15	Designated contracting statesAK	AK	EP
1997-08-29	Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI	PUAI	EP

Antitumor agent potentiator comprising il-6 antagonist

Abstract

Term

Priority claims7

Members25

Over the term

Events

Numbers

Titles3

Classification

Designated states1